BACKGROUND: Congestive heart failure (CHF) has become a major clinical and public health challenge with the aging of the population in China. However, the effect of the coexistence of multiple cardiovascular diseases on the prognosis of hospitalized patients with CHF remains unclear. A comparative analysis was performed to explore the etiology and comorbidities of CHF and in-hospital mortality in patients with CHF. HYPOTHESIS: The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with CHF. METHODS: All 6949 patients (4344 males, 2605 females) in the database with a principal ICD-9-CM discharge diagnosis of CHF were identified and divided into 5 groups according to the number of comorbidities. Cox proportional hazards regression was used to examine the association between the number of comorbidities and in-hospital mortality in patients with CHF. RESULTS: A single comorbidity was predominant in younger patients (18-39 years, P<0.001), whereas multiple comorbidities were predominant in the elderly (≥80 years, P<0.001). The most common single etiology was valvular heart disease, and the most common triple etiology was hypertension and diabetes mellitus complicated by coronary artery disease. Cox regression analysis showed a higher hospital mortality rate associated with an increased number of comorbidities (hazard ratio [HR] from 1.22 [95% CI: 0.89-1.68] to HR 3.49 [95% CI: 2.55-4.78], P<0.001). CONCLUSIONS: This study demonstrates the coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with CHF.
BACKGROUND:Congestive heart failure (CHF) has become a major clinical and public health challenge with the aging of the population in China. However, the effect of the coexistence of multiple cardiovascular diseases on the prognosis of hospitalized patients with CHF remains unclear. A comparative analysis was performed to explore the etiology and comorbidities of CHF and in-hospital mortality in patients with CHF. HYPOTHESIS: The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with CHF. METHODS: All 6949 patients (4344 males, 2605 females) in the database with a principal ICD-9-CM discharge diagnosis of CHF were identified and divided into 5 groups according to the number of comorbidities. Cox proportional hazards regression was used to examine the association between the number of comorbidities and in-hospital mortality in patients with CHF. RESULTS: A single comorbidity was predominant in younger patients (18-39 years, P<0.001), whereas multiple comorbidities were predominant in the elderly (≥80 years, P<0.001). The most common single etiology was valvular heart disease, and the most common triple etiology was hypertension and diabetes mellitus complicated by coronary artery disease. Cox regression analysis showed a higher hospital mortality rate associated with an increased number of comorbidities (hazard ratio [HR] from 1.22 [95% CI: 0.89-1.68] to HR 3.49 [95% CI: 2.55-4.78], P<0.001). CONCLUSIONS: This study demonstrates the coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with CHF.
Authors: Alain Rudiger; Veli-Pekka Harjola; Andreas Müller; Eero Mattila; Petrus Säila; Markku Nieminen; Ferenc Follath Journal: Eur J Heart Fail Date: 2005-06 Impact factor: 15.534
Authors: F Zannad; S Briancon; Y Juilliere; P M Mertes; J P Villemot; F Alla; J M Virion Journal: J Am Coll Cardiol Date: 1999-03 Impact factor: 24.094
Authors: Kirkwood F Adams; Gregg C Fonarow; Charles L Emerman; Thierry H LeJemtel; Maria Rosa Costanzo; William T Abraham; Robert L Berkowitz; Marie Galvao; Darlene P Horton Journal: Am Heart J Date: 2005-02 Impact factor: 4.749
Authors: H L Hillege; A R Girbes; P J de Kam; F Boomsma; D de Zeeuw; A Charlesworth; J R Hampton; D J van Veldhuisen Journal: Circulation Date: 2000-07-11 Impact factor: 29.690
Authors: Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen Journal: JAMA Date: 2004-07-21 Impact factor: 56.272
Authors: J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason Journal: Eur Heart J Date: 2003-03 Impact factor: 29.983
Authors: Hao Gao; Nan Qi; Liuyang Feng; Xingshuang Ma; Mark Danton; Colin Berry; Xiaoyu Luo Journal: Int J Numer Method Biomed Eng Date: 2017-02-16 Impact factor: 2.747
Authors: Yuan Yu; Hongzhao Zhang; Xi Li; Yuan Lu; Frederick A Masoudi; Harlan M Krumholz; Jing Li Journal: BMJ Open Date: 2018-05-10 Impact factor: 2.692